Topics:
ARS 2014|Breast Cancer|Colorectal Cancer|Leukemia & Lymphoma|Lung Cancer|Melanoma|ASCO 2014|Prostate Cancer|Browse All Topics

Blog

Featured Bloggers

Below are links to some of our more frequent bloggers, including their latest blog posts and other contributions:

Frederic W. Grannis, Jr., MD
Rebecca Bechhold, MD
David Eagle, MD
Craig R. Hildreth, MD
Paul R. Helft, MD
Richard Rosenbluth, MD

Blog

Six Points of Miscommunication Between Oncologists and Pathologists

Juneko Grilley-Olson, MD
Blog | July 16, 2014
By

Regardless of where you practice, good communication between you and your pathologist is the best way to ensure that correct testing is done. Here are six common points of miscommunication to watch out for.

Why Did CVS Decide to Stop Selling “Poison?”

Frederic W. Grannis, Jr, MD
Blog | July 11, 2014
By

When the media reported earlier this year that giant drugstore chain CVS had announced that it would stop selling tobacco products, it appeared to be a sudden, independent, and ethically responsible business decision. In fact, there is important background and subtext.

Seven Statements Oncologists Should Never Say to Their Patients

Craig R. Hildreth, MD
Blog | June 26, 2014
By

We can all agree that communication skills are essential to quality cancer care. Oncologists are expected to explain complex situations clearly. Be on the lookout for doctors who say any of these—it could be a sign that they need an attitude adjustment.

Breaking News!

Rebecca Bechhold, MD
Blog | June 23, 2014
By

Is there any truth in advertising? A recent study found that cancer center ads only emphasize positive outcomes, but other than direct-to-consumer marketing of pharmaceuticals that list all possible side effects, are you aware of any ads that state less than optimal outcomes?

The Growing Need for Specific Care of Geriatric Cancer Patients

Elizabeth Kessler, MD
Blog | June 20, 2014 | Blogs from the 2014 ASCO Street Team, ASCO 2014
By

Throughout the geriatric sessions we were continually reminded of our aging population, the fact that cancer is a disease of the aging, and of the mismatch in this increasing number of patients and the number of geriatric providers entering the workforce. General oncologists will need to understand the nuances of caring for older patients with cancer.

Using Pharmacokinetics to Optimize Older Chemotherapeutic Agents

Christine M. Walko, PharmD, BCOP
Blog | June 20, 2014 | Blogs from the 2014 ASCO Street Team, Colorectal Cancer, ASCO 2014
By

The landscape of cancer therapy is shifting from traditional cytotoxic chemotherapy towards targeted therapy with agents like tyrosine kinase inhibitors and monoclonal antibodies. However, these newer agents remain costly, and traditional chemotherapy remains the backbone for treating most malignancies.

Molecular Testing in 2014: Where We Are

Juneko Grilley-Olson, MD
Blog | June 13, 2014 | Blogs from the 2014 ASCO Street Team, ASCO 2014, Lung Cancer
By

Several factors affect physicians’ choice of genomic tests, including availability, speed, and cost. Traditionally allelotyping have been used, since they are fast and sensitive, even though they are not comprehensive.

Pages

Subscribe to Blog on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.